Effects of the humanized anti-adrenomedullin antibody adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis

Fulltext present in this item

Fulltext: 200063.pdf

Format: PDF

Description: publisher's version

Embargo: until further notice

Title:	Effects of the humanized anti-adrenomedullin antibody adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis
Author(s):	Geven, C.B.C.A.G.; Peters, E. ; Schroedter, Mathias; Struck, Joachim; Bergmann, A.; McCook, Oscar; Kox, M. ; Pickkers, P.
Publication year:	2018
Source:	Shock, vol. 50, iss. 6, (2018), pp. 648-654
ISSN:	1073-2322
DOI:	https://doi.org/10.1097/SHK.0000000000001102
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/200063
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Intensive Care
Journal title:	Shock
Volume:	vol. 50
Issue:	iss. 6
Page start:	p. 648
Page end:	p. 654

Faculty of Medical Sciences [66712]
Electronic publications [76821]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [168344]
Academic output Radboud University